drugset / Trial / NCT03018041
The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation
Phase 3
Completed
174 enrolled
Joe Chan
Aalborg University Hospital · collabDrammen sykehus · collabElverum Hospital · collabHaukeland University Hospital · collabPronova BioPharma · collabRikshospitalet University Hospital · collabSouth-Eastern Norway Regional Health Authority · collabUllevaal University Hospital · collabUniversity Hospital of North Norway · collabUniversity of Oslo · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a long-term intervention study on the effects of marine n-3 PUFAs in renal transplantation. Our hypothesis is that patients treated with marine n-3 PUFA supplementation will have less decline in kidney transplant function compared to patients treated with placebo.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2024-03-22
- Completion
- 2025-03-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovaza | Other / unclassified | 2.5 g | Oral |
Indications
No indication recorded.